Literature DB >> 10963964

The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures.

T M Walker1, P C Rhodes, C Westmoreland.   

Abstract

It is important to assess the usefulness of long-term in vitro liver models for studying chronic toxicity, since acute assays may not reflect the in vivo situation. A potential long-term hepatocyte culture (i.e. liver spheroids) was investigated and compared to primary rat hepatocyte monolayer cultures following exposure to methotrexate (MTX), a well-documented chronic hepatotoxin. Following up to 7 days' treatment with MTX, cultures were morphologically assessed and assayed for enzyme leakage, intracellular reduced glutathione (GSH) and adenosine triphosphate (ATP). Spheroids maintained higher concentrations of GSH over the 14-day culture and ATP was maintained, but at a concentration not significantly different from monolayer cultures. Treatment of monolayer cultures resulted in concentration-related decreases in GSH and ATP, accompanied by enzyme leakage. In contrast, only ATP was affected following treatment of spheroids for 7 days. Spheroids appeared to be less sensitive to exposure to MTX, when compared with monolayer cultures. This may result from the maintenance of cellular functions, or from the lack of compound penetration into the three-dimensional spheroid structure. Therefore, the usefulness of spheroids to chronic in vitro toxicity testing may be limited.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963964     DOI: 10.1016/s0887-2333(00)00036-9

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  14 in total

1.  Three-Dimensional In Vitro Hepatic Constructs Formed Using Combinatorial Tapered Stencil for Cluster Culture (TASCL) Device.

Authors:  Yoshitaka Miyamoto; Masashi Ikeuchi; Hirofumi Noguchi; Tohru Yagi; Shuji Hayashi
Journal:  Cell Med       Date:  2014-12-12

2.  Spheroid Formation and Evaluation of Hepatic Cells in a Three-Dimensional Culture Device.

Authors:  Yoshitaka Miyamoto; Masashi Ikeuchi; Hirofumi Noguchi; Tohru Yagi; Shuji Hayashi
Journal:  Cell Med       Date:  2015-08-26

3.  Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge.

Authors:  Maria Bokhari; Ross J Carnachan; Neil R Cameron; Stefan A Przyborski
Journal:  J Anat       Date:  2007-08-15       Impact factor: 2.610

4.  Towards a more representative in vitro method for fish ecotoxicology: morphological and biochemical characterisation of three-dimensional spheroidal hepatocytes.

Authors:  Matthew G Baron; Wendy M Purcell; Simon K Jackson; Stewart F Owen; Awadhesh N Jha
Journal:  Ecotoxicology       Date:  2012-06-26       Impact factor: 2.823

5.  Effects of medium composition on the morphology and function of rat hepatocytes cultured as spheroids and monolayers.

Authors:  G A Hamilton; C Westmorel; A E George
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

6.  Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures.

Authors:  C Shen; Q Meng; G Zhang; W Hu
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

7.  Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity.

Authors:  Suleyman Uraz; Veysel Tahan; Cem Aygun; Fatih Eren; Goksenin Unluguzel; Meral Yuksel; Omer Senturk; Erol Avsar; Goncagul Haklar; Cigdem Celikel; Sadettin Hulagu; Nurdan Tozun
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 8.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

9.  Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress.

Authors:  Adel Rezaei Moghadam; Soheil Tutunchi; Ali Namvaran-Abbas-Abad; Mina Yazdi; Fatemeh Bonyadi; Daryoush Mohajeri; Mohammad Mazani; Hassan Marzban; Marek J Łos; Saeid Ghavami
Journal:  BMC Complement Altern Med       Date:  2015-07-22       Impact factor: 3.659

10.  Metformin ameliorates methotrexate-induced hepatotoxicity.

Authors:  Najah R Hadi; Fadhil G Al-Amran; Asma Swadi
Journal:  J Pharmacol Pharmacother       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.